Literature DB >> 30240879

Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.

Maxime E S Bronzwaer1, Annekatrien C T M Depla2, Niels van Lelyveld3, Bernhard W M Spanier4, Yvonne H Oosterhout5, Monique E van Leerdam6, Manon C W Spaander7, Evelien Dekker1.   

Abstract

Colorectal cancer (CRC) screening is capable of reducing CRC-related morbidity and mortality. Colonoscopy is the reference standard to detect CRC, also providing the opportunity to detect and resect its precursor lesions: colorectal polyps. Therefore, colonoscopy is either used as a primary screening tool or as a subsequent procedure after a positive triage test in screening programs based on non-invasive stool testing or sigmoidoscopy. However, in both settings, colonoscopy is not fully protective for the occurrence of post-colonoscopy CRCs (PCCRCs). Because most PCCRCs are the result of colonoscopy-related factors, a high-quality procedure is of paramount importance to assure optimal effectiveness of CRC screening programs. For this reason, at the start of the Dutch fecal immunochemical test (FIT)-based screening program, quality criteria for endoscopists performing colonoscopies in FIT-positive screenees, as well as for endoscopy centers, were defined. In conjunction, an accreditation and auditing system was designed and implemented. In this report, we describe the quality assurance process for endoscopists participating in the Dutch national CRC screening program, including a detailed description of the evidence-based quality criteria. We believe that our experience might serve as an example for colonoscopy quality assurance programs in other CRC screening programs.
Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30240879     DOI: 10.1016/j.gie.2018.09.011

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

1.  Joint Advisory Group on Gastrointestinal Endoscopy (JAG) achieves enduring large-scale change.

Authors:  Roland Valori
Journal:  Frontline Gastroenterol       Date:  2019-01-11

2.  Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

Authors:  L J W Bosch; V Melotte; S Mongera; K L J Daenen; V M H Coupé; S T van Turenhout; E M Stoop; T R de Wijkerslooth; C J J Mulder; C Rausch; E J Kuipers; E Dekker; M J Domanico; G P Lidgard; B M Berger; M van Engeland; B Carvalho; G A Meijer
Journal:  Am J Gastroenterol       Date:  2019-12       Impact factor: 10.864

3.  Impact of the COVID-19 Pandemic on Surgical Colorectal Cancer Care in the Netherlands: a Multicenter Retrospective Cohort Study.

Authors:  Mando Filipe; Ellen de Bock; Ritch Geitenbeek; Djamila Boerma; Apollo Pronk; Joost Heikens; Milan Richir
Journal:  J Gastrointest Surg       Date:  2021-02-23       Impact factor: 3.452

4.  Substantial and sustained improvement of serrated polyp detection after a simple educational intervention: results from a prospective controlled trial.

Authors:  Arne G C Bleijenberg; Monique E van Leerdam; Marloes Bargeman; Jan Jacob Koornstra; Yasmijn J van Herwaarden; Manon Cw Spaander; Silvia Sanduleanu; Barbara A J Bastiaansen; Erik J Schoon; Niels van Lelyveld; Evelien Dekker; Joep E G IJspeert
Journal:  Gut       Date:  2020-03-05       Impact factor: 23.059

5.  Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology.

Authors:  Rumi Shin; Seongdae Lee; Kyung-Su Han; Dae Kyung Sohn; Sang Hui Moon; Dong Hyun Choi; Bong-Hyeon Kye; Hae-Jung Son; Sun Il Lee; Sumin Si; Won-Kyung Kang
Journal:  Ann Surg Treat Res       Date:  2021-02-26       Impact factor: 1.859

6.  Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands.

Authors:  Joost R C Lameijer; Adri C Voogd; Ruud M Pijnappel; Wikke Setz-Pels; Mireille J Broeders; Vivianne C G Tjan-Heijnen; Lucien E M Duijm
Journal:  Br J Cancer       Date:  2020-05-11       Impact factor: 7.640

7.  Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme.

Authors:  Jasper L A Vleugels; Lianne Koens; Marcel G W Dijkgraaf; Britt Houwen; Yark Hazewinkel; Paul Fockens; Evelien Dekker
Journal:  Gut       Date:  2019-12-10       Impact factor: 23.059

8.  Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.

Authors:  Hai Luo; Kexin Shen; Hongyan Sun; Ruiqi Li; Zeming Wang; Zhongshi Xie
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.